Intech Investment Management LLC Monte Rosa Therapeutics, Inc. Transaction History
Intech Investment Management LLC
- $10.2 Billion
- Q2 2025
A detailed history of Intech Investment Management LLC transactions in Monte Rosa Therapeutics, Inc. stock. As of the latest transaction made, Intech Investment Management LLC holds 29,870 shares of GLUE stock, worth $388,608. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,870
Previous 22,062
35.39%
Holding current value
$388,608
Previous $102,000
31.37%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding GLUE
# of Institutions
114Shares Held
58.4MCall Options Held
56.3KPut Options Held
0-
Nea Management Company, LLC Timonium, MD7.69MShares$100 Million2.88% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.33MShares$82.3 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA5.66MShares$73.6 Million1.0% of portfolio
-
Versant Venture Management, LLC San Francisco, CA5.65MShares$73.5 Million45.25% of portfolio
-
Baker Bros. Advisors LP New York, NY4.92MShares$64 Million0.22% of portfolio
About Monte Rosa Therapeutics, Inc.
- Ticker GLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,713,900
- Market Cap $608M
- Description
- Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...